Big Money Sentiment increased to 2.18 in 2018 Q3. It has change of 0.36, from 2018Q2’s 1.82. The ratio increased due to CDNA positioning: 6 sold and 28 reduced. 38 funds amassed positions and 36 increased positions. Investors holded 25.40 million in 2018Q2 but now own 28.20 million shares or 11.02% more. Caxton Assocs Lp owns 6,965 shs for 0.01% of their capital. 12 West Management Lp invested 1.08% of its capital in CareDx, Inc (NASDAQ:CDNA). Bridgeway Management accumulated 71,598 shs or 0.02% of the stock. California Public Employees Retirement Sys reported 0.01% stake. Blackrock reported 0% stake. Aqr Cap Management Limited Liability invested in 170,198 shs or 0% of the stock. State Board Of Administration Of Florida Retirement Sys stated it has 0% of its capital in CareDx, Inc (NASDAQ:CDNA). Fmr Ltd Liability Corp accumulated 20,000 shs. Deutsche Bank Ag reported 283,579 shs. Tower Research Cap Limited Liability (Trc) reported 146 shs stake. California State Teachers Retirement reported 50,948 shs or 0% of all its holdings. Friess Associates Ltd Liability Corp accumulated 122,800 shs. Canada Pension Plan Inv Board has invested 0.01% in CareDx, Inc (NASDAQ:CDNA). Moreover, Parallax Volatility Advisers LP has 0% invested in CareDx, Inc (NASDAQ:CDNA). Fred Alger Mgmt Inc invested in 3.44 million shs or 0.37% of the stock.
CDNA had 7 sales and 0 insider buys since September 4, 2018. This’s net activity of $8.93 million. On Thursday, September 13 Bell Michael Brian sold $409,920 worth of CareDx, Inc (NASDAQ:CDNA) or 16,355 shs. On Friday, October 5 King Sasha had sold 11,500 shs worth $282,900. On Tuesday, February 12 $776,100 worth of CareDx, Inc (NASDAQ:CDNA) was sold by Yee James P. On Wednesday, October 31 Gagnon Neil sold $2.94 million worth of CareDx, Inc (NASDAQ:CDNA).
Gagnon Securities Llc reduced its stake by 19.97% in Caredx Inc (CDNA), according to 2018Q3 SEC filling. The company’s stock declined 1.56% with the market as Gagnon Securities Llc sold 391,470 shares. The health care company at the end of 2018Q3 was valued at $45.25M. It’s down from 1.96 million at the end of the previous reported quarter. Now it had 1.57M shares held by the institutional investor . Caredx Inc has $1.18 billion MC. CDNA is touching $29 during the last trading session, after decreased 1.73%.Currently CareDx, Inc is uptrending after 302.12% change in last February 27, 2018. CDNA has also 676,839 shares volume. The stock outperformed the S&P500 by 302.12%.
About $353.18 million and $435.13M US Long portfolio Gagnon Securities Llc manages. According to a filing the fund increased its stake in Ensign Group Inc (NASDAQ:ENSG) by 222,060 shares to 467,289 shares, valued at $17.72M in 2018Q3. For a total of 70,165 shares it increased its holding in Carmax Inc (NYSE:KMX) by 45,966 shares in the quarter, and has risen its stake in Air Lease Corp (NYSE:AL).
On March, 28. Investors expect CareDx, Inc (NASDAQ:CDNA) to announce its quarterly earnings, according to Zacks. Analysts have anticipation on stock’s EPS of $-0.09. That’s up 18.18 % from last year’s $-0.11 EPS. -83.33 % EPS growth is what analysts predict. $-0.54 EPS was revealed for previous quarter.
For more CareDx, Inc (NASDAQ:CDNA) news published recently go to: Globenewswire.com, Globenewswire.com, Globenewswire.com, Globenewswire.com or Benzinga.com. The titles are as follows: “CareDx broadens HeartCare availability Nasdaq:CDNA – GlobeNewswire” published on September 17, 2018, “CareDx to Announce Fourth Quarter 2018 Financial Results on March 6th, 2019 – GlobeNewswire” on February 14, 2019, “CareDx Reports Preliminary Fourth Quarter and Full Year 2018 Financial Results – GlobeNewswire” with a publish date: January 07, 2019, “CareDx expands NGS Transplant Product Offerings Nasdaq:CDNA – GlobeNewswire” and the last “61 Biggest Movers From Friday – Benzinga” with publication date: February 19, 2019.
CareDx, Inc (NASDAQ:CDNA) Ratings Coverage
A total of 2 analysts rate CareDx (NASDAQ:CDNA) as follows: 2 “Buy”, 0 “Hold” and 0 “Sell”. Тherefore 100% are bullish. (NASDAQ:CDNA) has 3 ratings reports on Feb 27, 2019 according to StockzIntelligence. On Thursday, February 21 the rating was maintained by Piper Jaffray with “Buy”.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.